Progressive metastatic pheochromocytoma induced by multiple endocrine neoplasia type 2A with a lethal outcome

IJU Case Rep. 2022 Sep 6;5(6):459-463. doi: 10.1002/iju5.12514. eCollection 2022 Nov.

Abstract

Introduction: Patients with multiple endocrine neoplasia type 2A (MEN2A) harboring a pathological variant in the RET gene are characterized by medullary thyroid carcinoma (MTC), pheochromocytoma, and hyperparathyroidism. Although pheochromocytoma is currently defined as a malignant tumor, MEN2A-associated pheochromocytoma is known to have a small risk of metastasis.

Case presentation: The case was a 62-year-old Japanese male with bilateral pheochromocytoma, multiple metastases in the liver and bones, and a cardiac thrombus. Genetic testing revealed a pathological variant at codon 634 of the RET gene, thereby leading a diagnosis of MTC. We considered that the multiple metastases were due to MTC; however, a liver biopsy revealed metastasis of pheochromocytoma.

Conclusion: When pheochromocytoma precedes MTC, the diagnosis of MEN2A may be difficult.

Keywords: Metastatic pheochromocytoma; chemotherapy; embolization; multiple endocrine neoplasia type 2; thrombosis.

Publication types

  • Case Reports